Ionis Insider Trade: HR Executive Buys and Sells 50,000+ Shares Amid Bepirovirsen Breakout—Net 3,000 Shares Purchased as Confidence Rises in RNA Pipeline
Insightful look at Ionis Pharmaceuticals insider trades: why Shannon Devers is buying low, selling high and what it signals for RNA‑drug investors.
4 minutes to read